Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $788 | $1,168 | $1,359 | $1,565 |
| - Cash | $205 | $166 | $96 | $69 |
| + Debt | $147 | $9 | $9 | $9 |
| Enterprise Value | $730 | $1,010 | $1,272 | $1,505 |
| Revenue | $487 | $503 | $447 | $361 |
| % Growth | -3.1% | 12.4% | 23.8% | – |
| Gross Profit | $339 | $376 | $337 | $268 |
| % Margin | 69.6% | 74.7% | 75.4% | 74.1% |
| EBITDA | $92 | $178 | $167 | $129 |
| % Margin | 18.8% | 35.5% | 37.5% | 35.6% |
| Net Income | $50 | $128 | $113 | $81 |
| % Margin | 10.3% | 25.5% | 25.2% | 22.3% |
| EPS Diluted | 106.41 | 266.6 | 230.79 | 162.16 |
| % Growth | -60.1% | 15.5% | 42.3% | – |
| Operating Cash Flow | $82 | $111 | $160 | $62 |
| Capital Expenditures | -$8 | -$21 | -$14 | -$12 |
| Free Cash Flow | $74 | $90 | $145 | $50 |